The specific aims of Core M are to: 1. Provide consultation on psychosocial, biomedical factors, clinical factors, and prevention efforts affecting behavioral risk reduction or which impact therapy for HIV. The goal is to work with investigators, students, and fellows in order to develop, implement, and improve new and ongoing HIV research, clinical trials, and HIV treatment; 2. Assist investigators in implementing new and ongoing HIV research. The Core will also focus on recruitment and retention of populations and communities affected by the epidemic, particularly ethnic group members, women, and other vulnerable populations; 3. Facilitate university-wide partnerships among HIV investigators and the other CFAR Cores to facilitate multidisciplinary, bio-behavioral research, and program areas;and review grant applications for CFAR seed funding, or submission to other private, state, or federal institutions. Core faculty offer consultation on factors such as sexual risk taking, the effects of trauma and violence, substance abuse, neurological impairment and coping strategies that affect behavioral adherence to risk reduction strategies for affected and infected populations. Faculty also offer consultation on HIV strategies to improve health promotion in populations living with HIV/AIDS. The faculty have expertise in developing research designs that promote the recruitment and retention of diverse populations. Additionally, Core faculty assist investigators in developing and/or writing components of their grant applications that specifically relate to the expertise of the CFAR faculty member.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI028697-23
Application #
8377993
Study Section
Special Emphasis Panel (ZAI1-EC-A)
Project Start
Project End
2013-03-04
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
23
Fiscal Year
2012
Total Cost
$75,357
Indirect Cost
$15,113
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Woo, Jin Seok; Srikanth, Sonal; Kim, Kyun-Do et al. (2018) CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol 201:1174-1185
Jia, Qingmei; Bowen, Richard; Dillon, Barbara Jane et al. (2018) Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. Sci Rep 8:7009
Arfer, Kodi B; Tomlinson, Mark; Mayekiso, Andile et al. (2018) Criterion validity of self-reports of alcohol, cannabis, and methamphetamine use among young men in Cape Town, South Africa. Int J Ment Health Addict 16:45-52
Van, Christina; Condro, Michael C; Lov, Kenny et al. (2018) PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis. J Mol Neurosci :
Shannon, Chelsea Lee; Bristow, Claire; Hoff, Nicole et al. (2018) Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries. Sex Transm Dis 45:673-676
Furler, Robert L; Nixon, Douglas F; Brantner, Christine A et al. (2018) TGF-? Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction. Cancers (Basel) 10:
Sato, Kei; Misawa, Naoko; Takeuchi, Junko S et al. (2018) Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model. J Virol 92:
Leoh, Lai Sum; Kim, Yoon Kyung; Candelaria, Pierre V et al. (2018) Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma. J Immunol 200:3485-3494
Heard, Jeffrey J; Phung, Ivy; Potes, Mark I et al. (2018) An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation. BMC Cancer 18:69
Young, Sean D; Mercer, Neil; Weiss, Robert E et al. (2018) Using social media as a tool to predict syphilis. Prev Med 109:58-61

Showing the most recent 10 out of 942 publications